News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,178 Results
Type
Article (43029)
Company Profile (460)
Press Release (680688)
Multimedia
Podcasts (93)
Webinars (16)
Section
Business (209819)
Career Advice (2037)
Deals (36153)
Drug Delivery (105)
Drug Development (83870)
Employer Resources (173)
FDA (16550)
Job Trends (15193)
News (354515)
Policy (33283)
Tag
Academia (2662)
Accelerated approval (12)
Adcomms (26)
Allergies (98)
Alliances (51388)
ALS (115)
Alzheimer's disease (1505)
Antibody-drug conjugate (ADC) (168)
Approvals (16526)
Artificial intelligence (334)
Autoimmune disease (34)
Automation (19)
Bankruptcy (376)
Best Places to Work (11870)
BIOSECURE Act (21)
Biosimilars (125)
Biotechnology (345)
Bladder cancer (98)
Brain cancer (36)
Breast cancer (377)
Cancer (2973)
Cardiovascular disease (227)
Career advice (1706)
Career pathing (30)
CAR-T (196)
CDC (32)
Cell therapy (532)
Cervical cancer (22)
Clinical research (68827)
Collaboration (1076)
Company closure (3)
Compensation (703)
Complete response letters (28)
COVID-19 (2694)
CRISPR (66)
C-suite (346)
Cystic fibrosis (119)
Data (3065)
Decentralized trials (2)
Denatured (31)
Depression (71)
Diabetes (352)
Diagnostics (6509)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (131)
Drug shortages (29)
Duchenne muscular dystrophy (137)
Earnings (88889)
Editorial (45)
Employer branding (21)
Employer resources (149)
Events (117931)
Executive appointments (877)
FDA (18240)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (978)
Gene editing (145)
Generative AI (23)
Gene therapy (408)
GLP-1 (828)
Government (4612)
Grass and pollen (4)
Guidances (182)
Healthcare (19208)
HIV (42)
Huntington's disease (32)
IgA nephropathy (43)
Immunology and inflammation (167)
Immuno-oncology (10)
Indications (40)
Infectious disease (2871)
Inflammatory bowel disease (158)
Inflation Reduction Act (13)
Influenza (65)
Intellectual property (122)
Interviews (313)
IPO (16898)
IRA (48)
Job creations (3745)
Job search strategy (1447)
Kidney cancer (13)
Labor market (53)
Layoffs (534)
Leadership (20)
Legal (8054)
Liver cancer (80)
Longevity (11)
Lung cancer (416)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (405)
MASH (96)
Medical device (13636)
Medtech (13641)
Mergers & acquisitions (19975)
Metabolic disorders (891)
Multiple sclerosis (99)
NASH (20)
Neurodegenerative disease (132)
Neuropsychiatric disorders (39)
Neuroscience (2227)
NextGen: Class of 2025 (6794)
Non-profit (4573)
Now hiring (48)
Obesity (452)
Opinion (238)
Ovarian cancer (103)
Pain (113)
Pancreatic cancer (123)
Parkinson's disease (193)
Partnered (22)
Patents (306)
Patient recruitment (171)
Peanut (51)
People (59469)
Pharmaceutical (88)
Pharmacy benefit managers (22)
Phase I (21642)
Phase II (30375)
Phase III (22426)
Pipeline (1674)
Policy (216)
Postmarket research (2604)
Preclinical (9300)
Press Release (67)
Prostate cancer (146)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (493)
Real estate (6084)
Recruiting (67)
Regulatory (23199)
Reports (50)
Research institute (2431)
Resumes & cover letters (353)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (13)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3816)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (58)
The Weekly (60)
Vaccines (805)
Venture capital (57)
Weight loss (279)
Women's health (49)
Worklife (17)
Date
Today (84)
Last 7 days (361)
Last 30 days (1858)
Last 365 days (32091)
2025 (17410)
2024 (36407)
2023 (41086)
2022 (52343)
2021 (56853)
2020 (55000)
2019 (47530)
2018 (35810)
2017 (33143)
2016 (32491)
2015 (38552)
2014 (32359)
2013 (27313)
2012 (29446)
2011 (30047)
2010 (28221)
Location
Africa (741)
Alabama (67)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39872)
Australia (6632)
California (7629)
Canada (2383)
China (699)
Colorado (330)
Connecticut (334)
Delaware (195)
Europe (87336)
Florida (1128)
Georgia (249)
Hawaii (1)
Idaho (60)
Illinois (665)
India (28)
Indiana (366)
Iowa (19)
Japan (232)
Kansas (113)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1050)
Massachusetts (5773)
Michigan (248)
Minnesota (460)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2129)
New Mexico (30)
New York (2124)
North Carolina (1156)
North Dakota (9)
Northern California (3327)
Ohio (241)
Oklahoma (16)
Oregon (39)
Pennsylvania (1640)
Puerto Rico (17)
Rhode Island (37)
South America (1115)
South Carolina (34)
South Dakota (1)
Southern California (2847)
Tennessee (126)
Texas (1154)
United States (28403)
Utah (224)
Virginia (194)
Washington D.C. (75)
Washington State (664)
West Virginia (4)
Wisconsin (70)
724,178 Results for "argos therapeutics inc formerly merix bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 29, 2025
·
4 min read
Press Releases
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
July 17, 2025
·
6 min read
Press Releases
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
December 6, 2024
·
2 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Update
May 15, 2025
·
5 min read
China
Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market
The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially more than $4 billion.
May 20, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
May 21, 2025
·
1 min read
Press Releases
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering
May 29, 2025
·
5 min read
Press Releases
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook
May 8, 2025
·
16 min read
Press Releases
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
January 27, 2025
·
6 min read
Biotech Bay
Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids
Alamar Biosciences announced the commercial launch of the ARGO HT System for push-button, high sensitivity analysis of proteins in biofluids and the NULISAseq Inflammation Panel 250 for deep profiling of immune response.
January 4, 2024
·
3 min read
1 of 72,418
Next
